Vanda Pharmaceuticals
VNDA
#7861
Rank
ยฃ0.23 B
Marketcap
ยฃ4.05
Share price
3.65%
Change (1 day)
8.00%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.10 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ93.75 M15.38%
2023-12-31ยฃ81.26 M-8.16%
2022-12-31ยฃ88.48 M34.41%
2021-12-31ยฃ65.83 M11.9%
2020-12-31ยฃ58.83 M5.96%
2019-12-31ยฃ55.51 M24.28%
2018-12-31ยฃ44.67 M-18.45%
2017-12-31ยฃ54.78 M-14.48%
2016-12-31ยฃ64.06 M18.63%
2015-12-31ยฃ53.99 M672.22%
2014-12-31ยฃ6.99 M-88.38%
2013-12-31ยฃ60.15 M-22.56%
2012-12-31ยฃ77.67 M-19.05%
2011-12-31ยฃ95.95 M-15.53%
2010-12-31ยฃ0.11 B-9.3%
2009-12-31ยฃ0.12 B4590.62%
2008-12-31ยฃ2.67 M-59.6%
2007-12-31ยฃ6.61 M36.24%
2006-12-31ยฃ4.85 M64.44%
2005-12-31ยฃ2.95 M213.18%
2004-12-31ยฃ0.94 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
ยฃ46.94 B 46,175.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ68.37 B 67,299.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.22 B 83,915.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.76 B 57,831.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.80 B 85,466.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
ยฃ0.19 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ58.27 B 57,350.37%๐Ÿ‡บ๐Ÿ‡ธ USA